Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis — Stella

Home/Menstrual Bleeding, Heavy/PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis

View on ClinicalTrials.gov

Recruiting

Back to Menstrual Bleeding, Heavy trials

PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

OHSU, Portland, Oregon

Key details

Phase

Early testing / Safety & dosing

Sponsor

Oregon Health and Science University

Enrollment target

~70 participants

Started

July 2023

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 45 Years

Sex

Female only

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.